首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1725021

生物成分產業，全球市場 2025-2030

Biotic Ingredients Industry, Global, 2025-2030

出版日期: 2025年03月31日 | 出版商:

Frost & Sullivan | 英文 85 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

人乳寡糖(HMO) 後生元研究及產品開發進展推動轉型成長

近年來，由於益生菌、益生元和後生元領域的技術快速進步，生物製品產業發生了重大轉變。

消費者對益生菌益處的認知、技術創新以及歐洲有利的監管發展正在推動這一領域的成長。提高消費者對高纖維飲食治療益處的認知是益生元成長的關鍵動力。 2021 年，國際益生菌和益生元科學協會發布了後生元的共識定義，為研究人員和產業相關人員提供更清晰的解釋。這將推動後生元領域的產品創新和市場擴張。

雖然益生菌和益生元仍然是生物成分產業的關鍵組成部分，但由於後生元擁有強大的技術參數，並且先進的研究正在揭示其在腸道和免疫健康之外的潛力，預計後生元領域將在預測期內推動最大的成長。

根據應用，由於益生元在行業中的大量使用，預計在預測期內微生物友好型機能性食品和飲料將需要最多量的生物成分。另一個原因是研究的進步和製造商提供創新的生物成分，例如後生元和產孢益生菌。

從地理位置來看，亞太地區在生物成分需求方面佔據主導地位，這得益於消費者對預防性醫療保健的認知、可支配收入的增加、經濟的快速成長以及有利的法規環境。北美和歐洲是生物製藥，因為北美消費者在膳食補充劑上的支出很高，而歐洲的食品和飲料行業規模龐大。

Frost & Sullivan 在本報告中涵蓋了五個地區。北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。研究期間為2022年至2030年，以2024年為基準年，2025年至2030年為預測期間。

收益預測

2022 年基準年收益預估為 58.461 億美元，2022-2030 年研究期間複合年成長率為 6.5%。

主要競爭對手

益生菌

ADM
Biena
BioGaia
Biosearch Life
Cerbios Pharma
Clerici-Sacco Group
Daflon
Danin International
dsm-firmenich
Gnosis by Lesaffre
IFF
Jiangsu Wecare Biotechnology Co., LTD.
Kaneka Probiotic
Lab4 Probiotic
Lallemand
Morinaga Milk Industry Co. Ltd.
Natren
Nova
Novozymes
NZMP
Probi

益生元

Abbott Laboratories
ADM
Anderson Advanced Ingredients
BASF
Beneo GMBH
BioNeutra
Biosynth
Carbiotix
Cargill
Clasado Biosciences
Cosucra
Dextra Laboratories
dsm-firmenich
Elicylt SA
Fonterra (NZMP)
FrieslandCampina Ingredients
Fuji Nihon Seito Corporation
Galam
GeneChem
Gnubiotic Sciences SA
Grain Processing Corporation
IFF

後生元

ADM
Asahi Group
Bereum
dsm-firmenich
Glac Biotech Co Ltd
Humana Spain SL
IDLONG Bioscience Co. Ltd
Kerry
Kyowa Hakko (Kirin Holdings Co., Ltd.)
Morinaga Milk Industry Co. Ltd.
Novozymes
Sabinsa
Synformulas
SynBalance

競爭基準化分析：益生菌成分
競爭基準化分析：益生元成分
競爭基準化分析：後生元成分
益生菌成分：主要製造商的市場活動，2022-2024 年
益生元成分：主要製造商的市場活動，2022-2023 年
益生元成分：主要製造商的市場活動，2022-2024 年
後生元成分：主要製造商的市場活動，2023-2024 年

生物成分產業的成長要素

成長指標
驅動程式
促進因素分析
成長抑制因素
生長抑制分析
合成生物產業聚焦
市場趨勢
預測性觀察
收益預測
按產品類型預測收益
各地區收益預測
亞太地區各國收益預測
定價分析與預測假設
競爭格局

生長促進劑：益生菌成分

成長指標
益生菌簡介
益生菌價值鏈
收益預測
收益預測分析
按組件分類的收益預測
各組件收益預測分析
按應用預測收益
按應用分類的收益預測分析
按健康福利預測收益
按健康收益分類的收入預測分析
各地區收益預測
亞太地區各國收益預測
各地區收益預測分析

生長發生器：益生元成分

成長指標
益生元簡介
了解纖維與益生元
益生元價值鏈
收益預測
收益預測分析
按組件分類的收益預測
各組件收益預測分析
按應用預測收益
按應用分類的收益預測分析
按健康福利預測收益
按健康收益分類的收入預測分析
各地區收益預測
亞太地區各國收益預測
各地區收益預測分析

生長促進劑：後生元成分

後生元簡介
後生元價值鏈
成長指標
收益預測
收益預測分析
按應用預測收益
按應用分類的收益預測分析
按組件分類的收益預測
按健康福利預測收益
按成分和健康益處進行的收益預測分析
各地區收益預測
亞太地區各國收益預測
各地區收益預測分析

生物原料產業的成長機會領域

成長機會1：後生元作為成長型產品類型
成長機會二：益生元產品創新
成長機會三：拓展廣泛的治療領域

附錄：後續步驟

成長機會的益處和影響
後續步驟Next steps
附件列表
免責聲明

簡介目錄

Product Code: PFQ5-88

Research and Product Development Advances in Human Milk Oligosaccharides and Postbiotics are Driving Transformational Growth

The biotics industry has witnessed a remarkable transformation in recent years, driven by rapid innovations in each biotics segment: probiotics, prebiotics, and postbiotics.

Consumer awareness of probiotic benefits, innovations, and favorable regulatory developments in Europe drive the segment's growth. Increasing consumer awareness of the therapeutic benefits of a high-fiber diet is a crucial growth propeller for prebiotics. In 2021, the International Scientific Association for Probiotics and Prebiotics published the consensus definition of postbiotics, which enhanced clarity for researchers and industry stakeholders. This drives product innovation and market expansion in the postbiotics space.

While probiotics and prebiotics remain vital components of the biotic ingredients industry, the postbiotics segment will likely drive the most growth during the forecast period due to its strong technical parameters and as research continues to unveil their potential beyond gut and immune health areas.

By application, microbiome-friendly functional food and beverages will demand the most biotic ingredients during the forecast period due to the substantial use of prebiotics in the industry. Another reason is advancements in research and innovative biotic ingredient offerings by manufacturers, such as postbiotics and spore-forming probiotics.

Geographically, Asia-Pacific dominates the demand for biotic ingredients because of consumer awareness of preventive healthcare, increasing disposable income, fast-growing economies, and favorable regulatory environment. North America and Europe are the other major markets for biotic ingredients due to high consumer spending on dietary supplements in North America and the massive food and beverage industry in Europe.

Frost & Sullivan covers 5 regions in this report: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The study period is 2022 to 2030, with 2024 as the base year and 2025 to 2030 as the forecast period.

Revenue Forecast

The revenue estimate for the base year 2022 is $5,846.1 million with a CAGR of 6.5% for the study period from 2022 to 2030.

The Impact of the Top 3 Strategic Imperatives on the Biotic Ingredients Industry

Geopolitical Chaos

WHY

Despite inflationary pressures, the demand for biotic ingredients remained strong from 2022 to 2024.
For example, Chr. Hansen (now Novozymes), a probiotics market leader, reported a 17% organic sales growth in health and nutrition sector in 2022. This indicates a rebound in consumer interest in probiotic supplements following the COVID-19 pandemic.
Similarly, leading prebiotics manufacturer Beneo found that consumers prioritize product efficacy and proven health claims over price when choosing prebiotic products, even amid rising living expenses.

FROST PERSPECTIVE

Companies in this market will need to remain wary of inflationary pressure by offering reliable and science-backed claims to sustain premium positioning even in challenging financial times.

Disruptive Technologies

WHY

The biotics industry still faces formulation challenges in the more established product categories of viable and non-spore-forming probiotics. Currently, the most compelling innovations in the industry that can combat these challenges are prebiotics and spore-forming probiotics.
Prebiotics manufacturers focus on reducing dosage requirements to develop more novel formats; for instance, OptiBiotix offers Opti005, and FrieslandCampina offers Biotis(R) GOS-OP High Purity. Both ingredients can significantly increase the beneficial gut microbial load at low dosages.

FROST PERSPECTIVE

Disruptive new technologies can overcome the challenges associated with established biotics industry products. However, research is necessary to scientifically back claims of health benefits. Ingredient manufacturers should continue prioritizing R&D to support product innovations and formulations.

Transformative Megatrends

WHY

Several megatrends are having a transformative impact on the biotics industry. Artificial intelligence (AI) is transforming all industries, and this is no different. The human microbiome is incredibly complex, and the use of AI-driven systems to identify, characterize, and research microbial strains is likely to gain momentum in the probiotics and postbiotics space.
Personalization is a rapidly growing trend in the nutrition industry. Personalization technology is gaining momentum in the biotics industry, with microbiome testing kits, tailored probiotics, and AI-assisted programs offering consumers customized solutions.

FROST PERSPECTIVE

All these megatrends can potentially disrupt existing market participants and present significant opportunities for growth.
To stay competitive and meet the demand for innovative and effective solutions, options available to companies include investing in technology advancements, using data for personalized products, and developing new services.

Scope of Analysis

The research scope includes biotic ingredients like probiotics, prebiotics, and postbiotics that help maintain a healthy human microbiome and prevent the growth of pathogenic microorganisms.
The study's geographic scope is global and includes the following regions:
North America: The United States and Canada
Europe: European Economic Area and European Trade Association states, including the United Kingdom
Asia-Pacific (APAC): China, Japan, South Korea, Australia, New Zealand, Association of Southeast Asian Nations (Indonesia, Thailand, Singapore, Malaysia, and the Philippines), and South Asian countries (India, Pakistan, Bangladesh, Sri Lanka, and Nepal); country-level segmentation for Asia-Pacific is included in the research scope for each biotic ingredient
Latin America (LATAM): All LATAM countries, including Mexico
Middle East and Africa (MEA): Africa and all Middle Eastern countries, including Turkey

The study analyzes each biotic ingredient type with respect to application, health benefits, and region. The scope and segmentation of application and health benefits vary for each type of biotic ingredient, depending on its market landscape.

Probiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, medical food, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, beauty-from-within, sports nutrition, women's health (vaginal and urinary health, reproductive health), bone and joint health, and others (oral and eye health)

Prebiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and medical food

Postbiotics segmentation

By application: Dietary supplements, functional food and beverages, infant nutrition, and pharmaceuticals

By health benefit: Gut/Digestive health, immune health, brain health, metabolic health, and others (women's health, eye health, and beauty-from-within)

Key Competitors

Probiotics

ADM
Biena
BioGaia
Biosearch Life
Cerbios Pharma
Clerici-Sacco Group
Daflon
Danin International
dsm-firmenich
Gnosis by Lesaffre
IFF
Jiangsu Wecare Biotechnology Co., LTD.
Kaneka Probiotic
Lab4 Probiotic
Lallemand
Morinaga Milk Industry Co. Ltd.
Natren
Nova
Novozymes
NZMP
Probi

Prebiotics

Abbott Laboratories
ADM
Anderson Advanced Ingredients
BASF
Beneo GMBH
BioNeutra
Biosynth
Carbiotix
Cargill
Clasado Biosciences
Cosucra
Dextra Laboratories
dsm-firmenich
Elicylt S.A
Fonterra (NZMP)
FrieslandCampina Ingredients
Fuji Nihon Seito Corporation
Galam
GeneChem
Gnubiotic Sciences S.A
Grain Processing Corporation
IFF

Postbiotics

ADM
Asahi Group
Bereum
dsm-firmenich
Glac Biotech Co Ltd
Humana Spain S.L.
IDLONG Bioscience Co. Ltd
Kerry
Kyowa Hakko (Kirin Holdings Co., Ltd.)
Morinaga Milk Industry Co. Ltd.
Novozymes
Sabinsa
Synformulas
SynBalance

Growth Drivers

Research innovations drive the evolution of the gut microbiome industry.

Rising consumer awareness about probiotic benefits, innovations, and favorable regulatory developments in Europe drive the market growth of probiotics.

Increasing awareness of a high-fiber diet linked to therapeutic benefits among consumers is a key growth propeller for prebiotics.

ISAPP's publication of the consensus definition of postbiotics enhanced clarity for researchers and industry stakeholders, driving product innovation and market expansion.

Changes in government policies in China boost demand for biotic ingredients.

Growth Restraint

Biotic Ingredients: Growth Restraints, Global, 2025-2030

The declining birth rate globally and frequent infant formula recalls in the United States impact the growth of the infant nutrition industry and the demand for biotic ingredients.
The lack of harmonized regulation for biotic ingredients in EU countries hinders market growth in the region.
Lack of clear understanding and knowledge about biotic ingredients globally is restricting market growth.